Marrone Bio Innovations Posts Wider Quarterly Loss

Marrone Bio Innovations, Inc., a provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, posted a wider third-quarter net loss as expenses rose; however, revenue rose 16% in the period.

The net loss was $8.5 million in the quarter, compared with a loss of $7.2 million a year earlier.

Financial Highlights

  • GAAP revenues grew 31% to $14.8 million for the first nine months of 2017, compared to $11.4 million in the same year-ago period. GAAP revenues increased 16% to $4.2 million in the third quarter of 2017, compared to $3.6 million in the third quarter of 2016.
  • Product shipments1 grew 36% to $15.2 million for the first nine months of 2017, compared to $11.2 million in the same year-ago period. Product shipments were $3.1 million in the third quarter of 2017, compared to $3.1 million in the third quarter of 2017.
  • Gross margin increased to 41.2% for the first nine months of 2017, compared to 30.6% in the same year-ago period. Gross margin increased significantly to 40.9% in the third quarter of 2017, compared to 31.4% in the third quarter of 2016.
  • In October 2017, the Company entered into an unsecured promissory note with an investor, enabling the funding of certain tranches at the lender’s sole discretion. To date, the Company has received $2.0 million in funding under the note.

“We experienced several noteworthy catalysts in the third quarter of 2017, such as completion of our Grandevo WDG granulation line, as well as receiving EPA registration for MBI-110, which is the seventh product we’ve commercialized in 11 years,” said Dr. Pam Marrone, CEO of MBI. “Despite these major events, unfavorable weather conditions reduced the number of expected sprays in several of our key markets. Historically, the third quarter produces the lowest sales of the year and is the most unpredictable, evidenced by hurricanes Irma and Maria which significantly impacted our sales in Florida and Puerto Rico. Fortunately, our portfolio approach to product development and marketing diversifies our revenue base and reduces the impact of any one variable on the success of the company as a whole, and allowed us to achieve above industry-average growth for the first nine months of 2017.

“We remain positive on the long-term outlook of our business and have made significant progress in penetrating the United States market and abroad. To that end, we have greatly expanded our reach in international markets through select partnerships with regionally significant firms such as ÉLÉPHANT VERT in North Africa, Kenya Biologics in Kenya and Tanzania. We have taken significant steps to increase product awareness in the substantial Central and South American market, such as sponsoring grower education events in Honduras and Chile, as well as successfully advancing field trials in Brazil, which have shown tremendous results to-date.

“We’ve also made an immense amount of progress on the R&D front and are near completing the development of our first generation bio-herbicide, MBI-014, which remains on track for EPA submission in the near-term. MBI-014 will address one of the largest needs of organic farming—controlling weeds—and we believe it will be the first new mode of action herbicide in 25 years. Also in the third quarter, on October 27, 2017, we received EPA registration for MBI-110—which we branded ‘Stargus™’, for specialty crops and ‘Amplitude™’ for row crops. To our knowledge, no other agricultural company has successfully commercialized 7 new agricultural products from 6 active ingredients in such a short amount of time.”

Dr. Marrone concluded: “These R&D advancements, paired with the considerable progress in advancing distribution and product awareness, are translating into greater market opportunities and enhanced potential to create shareholder value.”

Recent Operational Highlights

  • Realized exceptional results from field trials in Brazil for Regalia®, Grandevo®, Majestene®, and Venerate®. MBI now anticipates a clear path to completion of the registration process in the country, paving the way to commercial sales in the large Brazilian crop protection market.
  • Received EPA registration for MBI-110, branded “Stargus™” for specialty crops and “Amplitude™” for row crops. MBI plans to launch Stargus™ in the United States market in 2017.
  • Completed the development of MBI-014 (formerly 010), an organic bio-herbicide that is set for an EPA submission in the near-term.
  • Albaugh, a major row crop seed treatment provider, had a successful first season with the BioST seed treatment containing an MBI microorganism. Preliminary results are positive and point to substantial yield increases over the standards.
  • Developed a strategy and focus to address grower demand of MBI products within the cannabis market through the creation of smaller pack sizes, hiring a cannabis segment sales specialist and utilizing Amazon as a direct-to-consumer sales channel.
  • As part of MBI’s collaboration with Evogene, transgenic plants carrying MBI’s insecticidal genes were developed and one candidate showed promising results (100% kill) against cabbage looper. Additional tests are in progress.
  • Joined a pilot project with AgShift, a Santa Clara-based agriculture technology startup, to assess the impact of the use of biological pesticides on the quality of fresh produce.
  • Signed new distribution agreements in Africa with regionally significant firms such as ÉLÉPHANT VERT in North Africa and Kenya Biologics in Kenya and Tanzania.
  • Finalized a distribution agreement with a large water treatment company for Zequanox.
  • Currently in discussions with several food companies about how to best transition growers to organic and help their grower suppliers with specific pest and disease problems.
  • Sponsored educational symposia for growers in Honduras and Chile with prominent local organizations to spread awareness of modern agricultural production technologies, including the use of biopesticides and stimulants in specialty crops.
  • Completed construction of the Grandevo WDG granulation line at MBI’s Marrone Michigan Manufacturing facility. This is currently producing a second-generation formulation to allow MBI to meet anticipated demand for this innovative new formulation.
  • Discovered new methods to increase the potency of Majestene and Grandevo, driving notably higher gross margins and increasing the effective capacity of the Marrone Michigan Manufacturing facility.
Topics: ,

Leave a Reply

Biopesticides

Pam Marrone
Asia

Marrone Enters Distribution Partnership in Vietnam, Cambodia

Key factors driving the rapid adoption of biologicals in Vietnam include pesticide residue problems in agro-products for local consumption, new requirements for Maximum Residue Levels on agro-products imported to the EU and U.S., and a growing number of banned pesticides.

Biopesticides

STK REGEV Biofungicide Now Registered in Argentina

STK bio-ag technologies, the innovative Israeli-based leader in bio-ag technologies for sustainable crop protection and aquaculture, has announced its ‘hybrid’

Biopesticides

BioConsortia Promotes Dr. Hong Zhu to Sr. VP of Research and Development

BioConsortia, Inc., innovator of microbial solutions for natural plant trait enhancement and yield improvement, has promoted Dr. Hong Zhu to

Biopesticides

Marrone Bio Innovations Submits Novel Bioherbicide for EPA Approval

Marrone Bio Innovations, Inc. (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf

Americas

PepsiCo in Deal with Arysta LifeScience Chile on Biological Products

Under the agreement, the select group of Chilean potato farmers that supplies PepsiCo on an exclusive basis will use the solutions from the Arysta LifeScience Pronutiva program, which combines traditional crop protection inputs with biological solutions.

Biopesticide-lab-featured-image
Biopesticides

Biorational Processes in Biopesticide Discovery and Development

Agchem companies are expanding their biopesticide R&D and portfolios, driven by stricter pesticide regulatory requirements, consumer awareness regarding hazards caused

Biopesticides

3 Questions with BioTecnologie BT’s Piffanelli on EU Regulatory Environment

BioTecnologie BT is a Perugia, Italy-based contract research organization (CRO) specialized in the regulatory testing of biopesticides and biostimulants.

Biopesticides

Corbion CEO Tjerk de Ruiter Appointed as New EuropaBio Chairman

EuropaBio’s Executive Board and General Assembly of Members confirmed the appointment of Tjerk de Ruiter as Chairman of the association.

Biopesticides

FaunaSmart, BioScience Solutions Form Innovative Collaboration in Crop Protection

FaunaSmart and BioScience Solutions have announced a cooperation within strategic business development and innovation strategies in crop protection. Harry Teicher,

Biopesticides

FMC, Chr. Hansen Extend Collaboration on Natural Crop Protection

FMC Corp. and Chr. Hansen have announced a five-year extension of their collaboration to develop and commercialize natural solutions for the agricultural industry.

Biopesticides

Tradecorp Acquires Spain’s Idai Nature

Idai Nature is currently present in 35 countries and has posted annual growth of more than 30% in recent years. The company’s consolidated revenues amount to 16 million euros.

Biopesticides

A (Surprisingly Long) Biopesticide Timeline

The application of biopesticides in plant protection is certainly not a new innovation. A few examples are presented in the

Biopesticides

Marrone Bio Innovations Names Hammill as Chief Commercial Officer

Most recently, Hammill was Chief Operating Officer at Pivot Bio, a startup company.

Corn-field
Biopesticides

Biopesticides: Assessing the Opportunities and Challenges in R&D, Formulation

Editor’s note: Dr. Harry Teicher, an independent Strategic R&D consultant with over 20-plus years of AgChem and BioScience R&D Management

Americas

STK, BASF in Deal to Expand Distribution in Brazil

STK will grant BASF exclusive rights to maket and sell the biological fungicide bactericide in the country.

pheromone-based-innovation-combats-tuta-absoluta-in-tomatoes
Africa/Middle East

Affinity in East Africa: Marrone Bio Innovations Finds Harmonious Partner in Kenya Biologics

Farmers in East Africa are set to benefit from a wide range of zero-residue biopesticides that will help to increase

Americas

Marrone Bio Innovations Enters Partnership with Israel’s Lidorr

Lidorr Chemicals Ltd., will develop and market three of MBI's products in Israel.

Crop-Field
Biopesticides

IPM and ICM: The Unique Opportunities and Challenges for Biopesticides

Integrated crop management (ICM) is a holistic approach to crop management, integrating agricultural and environmental management practices such as optimal

Biopesticides

Monsanto, AgriMetis Enter Global Licensing Agreement

The agreement includes an exclusive global license from AgriMetis to Monsanto for agricultural research in row, vegetable, and other crops for a three-year period.

Latest News

Markets

Trump Trade War Divides Farming World as China Demand Shifts

Soybeans have become something of a poster child for the U.S.-China trade war, with everyone from Treasury Secretary Steven Mnuchin

Asia

India Could Fill Gap in Agricultural Imports Amid China-U.S. Trade War

The ongoing China-U.S. trade dispute will provide a chance for China and India to strengthen their agricultural trade, which will

Industry News

Escalating Trade War with China Will Increase Damage to American Soybean Farmers

The Administration’s decision to impose 10% tariffs on an additional $200 billion in Chinese imports — and China’s subsequent retaliation

Plant Health

Favorable Soil pH: Does it Really Increase Nutrient Use Efficiency?

More than ever agriculture needs to follow principles of sustainability that ensure build up and maintenance of long-term soil productivity,

Plant Health

Diagnosing and Mapping the Need for Soil Improvement in Brazil

Brazil has lacked the data for creating a soil fertility survey that could be used for assessing if any nutritional